5 Best New Penny Stocks to Buy Now

3. Theseus Pharmaceuticals, Inc. (NASDAQ:THRX)

Number of Hedge Fund Holders: 16

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) is a biopharmaceutical company that is engaged in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. In July Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) took a nosedive after the company said it will abandon its lead asset THE-630 for gastrointestinal stromal tumors.

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) will now focus on THE-349, an EGFR inhibitor for EGFR mutant non-small cell lung cancer. Out of the 943 hedge funds tracked by Insider Monkey 16 hedge funds reported owning stakes in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX). The biggest hedge fund stakeholder of Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) was Samuel Isaly’s OrbiMed Advisors which had a $153 million stake in the company.